• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

UQ opens new era in cancer research and drug development

Bioengineer by Bioengineer
March 28, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Centre for Advanced Imaging, University of Queensland

New cancer-fighting drugs could emerge from The University of Queensland in coming years, thanks to a state-of-the-art imaging facility opened today.

A $2.5 million grant from the Australian Cancer Research Foundation (ACRF) enabled the purchase of a large-bore PET-CT scanner and an upgrade of the centre's existing Magnetic Resonance Imaging (MRI) facilities.

The new ACRF Facility for Molecular Imaging Agents in Cancer is housed in UQ's Centre for Advanced Imaging (CAI).

CAI director Professor David Reutens said the facility's opening today would enable "a new paradigm" in comparative oncology by allowing researchers to examine the effects of tiny doses of anti-cancer drugs in both human and animal cancers at a cellular level.

"We are using molecular imaging to improve cancer detection, characterisation, treatment and monitoring," he said.

"The new facility addresses a key issue in enhancing the success of clinical trials on human cancer therapies.

"It also builds on the long-term development of world-class facilities in health and medical bioscience and research in Queensland, linking with other imaging capabilities such as the Herston Imaging Research Facility and the TRI Innovation and Translation Centre.

"Researchers will use naturally occurring cancers in companion animals such as dogs to bridge the gap between conventional preclinical models and human trials, facilitating clinical translation of new drugs, devices, and imaging procedures for human cancers," Professor Reutens said.

He said the CAI's Comparative Oncology research program was the first of its kind in Australia.

Australian Cancer Research Foundation CEO Professor Ian Brown said the ACRF Facility for Molecular Imaging Agents in Cancer offered a new opportunity to better understand cancer in its many forms.

"It provides a chance for the development of new approaches for the prevention, detection and treatment of cancer," he said.

"The ACRF supporters who made this grant possible know that the investment in state-of-the-art technology when placed in the hands of the best researchers will lead to the breakthroughs that we all desire."

"The facility will build on the long-term development of world-class facilities in health and medical bioscience and research in Queensland, linking with other imaging capabilities such as the Herston Imaging Research Facility and the TRI Innovation and Translation Centre.

"Researchers in Australia are among the best in the world and we're delighted to be supporting the cutting-edge work of the teams working together at UQ.

"Research and innovation are our best means of finding ways to end cancer."

###

Media Contact

Nina Moore
[email protected]
61-733-651-785
@uq_news

http://www.uq.edu.au

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Unraveling the Future: Advances in Solar Cell Material Development

September 24, 2025
5G Deployment: Faster Speeds Not Always Guaranteed Compared to 4G

5G Deployment: Faster Speeds Not Always Guaranteed Compared to 4G

September 24, 2025

Novel Technique for Lateral Femoral Cutaneous Nerve Ablation

September 24, 2025

Unveiling Fusarium oxysporum Infection in Chickpeas

September 24, 2025
Please login to join discussion

POPULAR NEWS

  • Physicists Develop Visible Time Crystal for the First Time

    Physicists Develop Visible Time Crystal for the First Time

    70 shares
    Share 28 Tweet 18
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    50 shares
    Share 20 Tweet 13
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    49 shares
    Share 20 Tweet 12
  • Rapid Spread of Drug-Resistant Fungus Candidozyma auris in European Hospitals Prompts Urgent Warning from ECDC

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling the Future: Advances in Solar Cell Material Development

5G Deployment: Faster Speeds Not Always Guaranteed Compared to 4G

Novel Technique for Lateral Femoral Cutaneous Nerve Ablation

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.